Fujito et al. considered that three preoperative clinical factors could be able to predict the BRAF mutation in PCPs with a high sensitivity and specificity: age above 18 years, a supradiaphragmatic tumor location and absence of intratumoral calcification [62]. This evidence concerns the gene BRAF and neoplasm.